Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
ropinirole alpha adrenergic receptor small molecule NA drugbank Secondary Parkinson Disease[MeSHID:D010302]
Restless Legs Syndrome[MeSHID:D012148]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 NA approved,investigational antagonist
ropinirole alpha adrenergic receptor small molecule NA drugbank Secondary Parkinson Disease[MeSHID:D010302]
Restless Legs Syndrome[MeSHID:D012148]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 NA approved,investigational antagonist
ropinirole alpha adrenergic receptor small molecule NA drugbank Secondary Parkinson Disease[MeSHID:D010302]
Restless Legs Syndrome[MeSHID:D012148]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 NA approved,investigational antagonist
ropinirole alpha adrenergic receptor small molecule NA drugbank Secondary Parkinson Disease[MeSHID:D010302]
Restless Legs Syndrome[MeSHID:D012148]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 NA approved,investigational antagonist
ropinirole alpha adrenergic receptor small molecule NA drugbank Secondary Parkinson Disease[MeSHID:D010302]
Restless Legs Syndrome[MeSHID:D012148]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 NA approved,investigational antagonist
ropinirole alpha adrenergic receptor small molecule NA drugbank Secondary Parkinson Disease[MeSHID:D010302]
Restless Legs Syndrome[MeSHID:D012148]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 NA approved,investigational antagonist
ropinirole dopamine d2 receptor small molecule Successful target TTD , drugbank , DGIDB Secondary Parkinson Disease[MeSHID:D010302]
Restless Legs Syndrome[MeSHID:D012148]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 1.17 approved,investigational agonist
ropinirole dopamine d3 receptor small molecule Successful target TTD , drugbank , DGIDB Secondary Parkinson Disease[MeSHID:D010302]
Restless Legs Syndrome[MeSHID:D012148]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 1.65 approved,investigational agonist
ropinirole dopamine d4 receptor small molecule NA drugbank , DGIDB Secondary Parkinson Disease[MeSHID:D010302]
Restless Legs Syndrome[MeSHID:D012148]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Parkinson Disease[MeSHID:D010300]		 0.99 approved,investigational agonist
click here to return to the previous page